Strategic Intelligence for the Life Science Industry, Enhanced by AI
Turn competitive complexity into commercial advantage.
We help biotech, pharma, and medtech teams see their market clearly, and move first.
Life Science Intelligence
Three ways intelligence changes the outcome.
Same methodology your team already trusts: monitoring, primary & secondary research, and Key Intelligence Question-driven analysis, now easier to act on.
RISK
See the threat before it reaches your pipeline.
Track the competitive and regulatory shifts that put R&D timelines and funding at risk, so they don’t become surprises in a board meeting.
OPPORTUNITY
Move on openings while they’re still open.
Spot emerging therapeutic areas, in-licensing targets, and partners early enough to actually act on them.
STRATEGY
Build a position competitors can’t easily copy.
Turn raw intelligence into differentiated brand and portfolio strategy, grounded in how your market really behaves.
“Yamina has very strong professional skills. She developed and ran a tailored seminar on Competitive Intelligence for our specific purposes.”
Frank Faucher, PhD: Bristol-Myers Squibb
Trusted alongside
USA · San Francisco · Europe · Paris · UAE · Dubai
“Wow, thank you! I’ve only just gotten probably not even half way through and I’m just very appreciative of all that’s in here. The additional quotes from PIs are great as well!”
Vice President, Portfolio Strategy, New Product Planning
Biotech · South San Francisco
“Thank you so much to you and your team for providing this report on a Sunday morning. Really appreciate your support and collaboration.”
Competitive Intelligence Manager
Major Pharma · South San Francisco
“Thank you very much for providing the report so early. Really appreciate it, and special thanks to your team for working over the weekend.”
Director, Global Competitive Intelligence
Major Pharma · New Jersey
Founder & CEO
Yamina Hakem
Yamina founded GlobalReach BI in 2013 and built it from the ground up into a strategic and competitive intelligence practice trusted by top global pharmaceutical and biotech companies. Over more than 25 years in life sciences, she has led enterprise sales and intelligence programs spanning oncology, immunology, biomarkers, medical devices, and AI-enabled R&D, prior to which she held global and regional sales leadership roles at Thomson Reuters across Europe and the US.
She is hands-on with the AI technology behind SPRING, teaches AI strategy in Executive MBA programs at Ecole Supérieure de Commerce in France, and serves as a board advisor to AI-driven drug-discovery companies Pharmacelera and Theremia. Yamina was nominated by the French Government as a Conseiller du Commerce Extérieur to represent French economic interests abroad, and is fluent in English, French, and Italian.
AI Strategy Instructor
Board Advisor, AI Drug Discovery
Conseiller du Commerce Extérieur Français
